Current and Emerging Treatment Options for Patients with Relapsed Myeloma

Current and Emerging Treatment Options for Patients with Relapsed Myeloma

Show other versions (1)

Bibliographic Details
Main Authors:	Roberto Castelli, Roberta Gualtierotti, Nicola Orofino, Agnese Losurdo, Sara Gandolfi, Massimo Cugno
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-08-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/current-and-emerging-treatment-options-for-patients-with-relapsed-myel-article-a3837

Similar Items

Current and Emerging Treatment Options for Patients with Relapsed Myeloma
by: Roberto Castelli, et al.
Published: (2013-01-01)

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
by: Massimo Offidani, et al.
Published: (2021-02-01)

Current Status and Challenges in Treatment of Relapsed/Refractory Multiple Myeloma
by: WAN Yike, et al.
Published: (2019-09-01)

Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
by: Luo XW, et al.
Published: (2018-08-01)

Ixazomib in the treatment of relapsed multiple myeloma
by: S. V. Semochkin
Published: (2018-07-01)

RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY
by: María-Victoria Mateos, et al.
Published: (2015-07-01)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
by: van de Donk NW, et al.
Published: (2012-08-01)

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
by: Christopher T. Su, et al.
Published: (2021-07-01)

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2020-11-01)

Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
by: Dawn Swan, et al.
Published: (2019-06-01)

Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?
by: Thumallapally N, et al.
Published: (2016-08-01)

Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases
by: Roberta Gualtierotti, et al.
Published: (2018-12-01)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

Treatment of relapsed, refractory multiple myeloma: focus on new drugs
by: Angelo Maiolino
Published: (2020-10-01)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
by: Gupta VA, et al.
Published: (2013-05-01)

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma
by: Fostier K, et al.
Published: (2012-09-01)

Pleural infiltration in a relapse of multiple myeloma
by: Joud Zanabili Al-Sibai, et al.
Published: (2017-09-01)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
by: Roberta Fedele, et al.
Published: (2015-01-01)

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
by: Sarosiek S, et al.
Published: (2019-10-01)

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia
by: Felicetto Ferrara, et al.
Published: (2019-02-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Selinexor in relapsed/refractory multiple myeloma
by: Joshua Richter, et al.
Published: (2020-06-01)

Carfilzomib for relapsed and refractory multiple myeloma
by: Groen K, et al.
Published: (2019-04-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Current and emerging treatment options for uveal melanoma
by: Pereira PR, et al.
Published: (2013-08-01)

Current and emerging treatment options for nasopharyngeal carcinoma
by: Spratt DE, et al.
Published: (2012-10-01)

Birdshot uveitis: current and emerging treatment options
by: Menezo V, et al.
Published: (2013-12-01)

Current and emerging treatment options in the management of lupus
by: Jordan N, et al.
Published: (2016-03-01)

Posttraumatic epilepsy: current and emerging treatment options
by: Paiva WS, et al.
Published: (2014-11-01)

Current and Emerging Pharmacological Treatment Options for Dementia
by: John M. Ringman, et al.
Published: (2006-01-01)

Tratamento do Mieloma Múltiplo recidivado Relapsed Multiple Myeloma treatment
by: Vania T. M. Hungria
Published: (2007-03-01)

Current and Emerging Pharmacotherapies for the Treatment of Relapsed Small Cell Lung Cancer
by: Binu S. Nair Md, et al.
Published: (2011-01-01)

Relapse of Multiple Myeloma Presenting with Biliary Obstruction
by: Alan Coss, et al.
Published: (2010-01-01)

Bendamustine in patients with relapsed or refractory multiple myeloma
by: Michael M, et al.
Published: (2010-01-01)

CENTRAL NERVOUS SYSTEM RELAPSE OF MULTIPLE MYELOMA
by: Maria Qubtia, et al.
Published: (2019-03-01)

The role of carfilzomib in relapsed/refractory multiple myeloma
by: Andrew J. Yee
Published: (2021-06-01)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
by: Amir Garakani, et al.
Published: (2020-12-01)

Post-traumatic epilepsy: current and emerging treatment options
by: Szaflarski JP, et al.
Published: (2014-08-01)

Current and emerging treatment options in the management of Friedreich ataxia
by: Michelangelo Mancuso, et al.
Published: (2010-07-01)

Current and emerging treatment options for pediatric eosinophilic esophagitis
by: Elitsur Y
Published: (2013-09-01)